IP Library Granted Patent US 8,445,655
Granted Patent B2
US 8,445,655 · App. 12/305,102 · Granted May 21, 2013

Functional nucleic acid ligands to fluorescent proteins

Inventors: Michael Kotlikoff (Ithaca, NY); John T. Lis (Ithaca, NY); Bo Shui (Ithaca, NY); Hua Shi (Ithaca, NY)
Assignee: Cornell Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,445,655
App. No.
12/305,102
Granted
May 21, 2013
Kind
B2
Abstract

The present invention relates to a nucleic acid aptamer having a first domain that binds to a fluorescent protein. The nucleic acid aptamer forms a molecular complex whereby the aptamer binds a fluorescent protein at the first domain. A constructed DNA molecule, expression systems, and host cells containing the molecular complex are also disclosed. The invention also relates to a system containing a first DNA molecule encoding the nucleic acid aptamer of the present invention and a second DNA molecule encoding a fluorescent protein capable of being bound by the first domain. Methods of detecting a molecular target and determining location of a molecular target using the nucleic acid aptamer of the invention are also disclosed.

Claims (29)

1. A nucleic acid aptamer comprising:

a core region comprising the sequence of SEQ ID NO:19;

5′ primer region and a 3′ primer region; and

one or both of a 5′ random nucleotide sequence region and a 3′ random nucleotide sequence region, wherein the nucleic acid aptamer has a secondary structure comprising three stems and a central loop and binds to a fluorescent protein selected from GFP, eGFP, eCFP, and eYFP.

2. The nucleic acid aptamer according to claim 1 , wherein the nucleic acid aptamer reversibly binds to the fluorescent protein.

3. A molecular complex comprising the nucleic acid aptamer according to claim 1 and a fluorescent protein selected from GFP, eGFP, eCFP, and eYFP bound to the nucleic acid aptamer.

4. The molecular complex according to claim 3 , wherein the nucleic acid aptamer is reversibly bound to the fluorescent protein.

5. The molecular complex according to claim 3 , wherein the binding of the nucleic acid aptamer alters fluorescence of the fluorescent protein.

6. A host cell containing the molecular complex according to claim 3 .

7. A method of detecting a molecular target comprising:

providing the molecular complex according to claim 3 and

contacting the molecular target with the molecular complex under conditions effective to cause a change in fluorescence of the fluorescent protein, whereby the change in fluorescence detects presence of the molecular target.

8. The method according to claim 7 , wherein said contacting causes release of the fluorescent protein from the nucleic acid aptamer, an increase in fluorescence, or a decrease in fluorescence, or said contacting inhibits fluorescence.

9. The method according to claim 7 , wherein said contacting is carried out in a cell.

10. The method according to claim 9 , wherein said providing is carried out by recombinantly expressing the molecular complex in the cell.

11. A method of determining location of a molecular target comprising:

providing the molecular complex according to claim 3 ;

contacting the molecular target with the molecular complex; and

detecting the fluorescence of the fluorescent protein, whereby location of the molecular target is determined.

12. The method according to claim 11 , wherein said contacting is carried out in a cell.

13. The nucleic acid aptamer according to claim 1 comprising both the 5′ random nucleotide sequence region and the 3′ random nucleotide sequence region.

14. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have nucleotide sequence of SEQ ID NO:22.

15. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have the nucleotide sequence of SEQ ID NO:23.

16. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have the nucleotide sequence of SEQ ID NO:24.

17. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have the nucleotide sequence of SEQ ID NO:25.

18. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have the nucleotide sequence of SEQ ID NO:26.

19. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have the nucleotide sequence of SEQ ID NO:27.

20. The nucleic acid aptamer according to claim 13 , wherein the 5′ random nucleotide sequence region, the core region, and the 3′ random nucleotide sequence region have the nucleotide sequence of SEQ ID NO:28.

21. The nucleic acid aptamer according to claim 1 , wherein the aptamer has the nucleotide sequence of SEQ ID NO:29.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2009
From: KOTLIKOFF, MICHAEL; LIS, JOHN; SHUI, BO; SHI, HUA
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 022239/0590 →
Continuity (2)
Provisional Application 60804982 · Jun 16, 2006
Related Publication 20090197271A1 · Aug 6, 2009